Related references
Note: Only part of the references are listed.Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
Thierry Roger et al.
BLOOD (2011)
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells
W. Song et al.
LEUKEMIA (2011)
A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma
Monica Galli et al.
ANNALS OF HEMATOLOGY (2010)
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation
Jerome Lugrin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
A. Rocca et al.
BRITISH JOURNAL OF CANCER (2009)
Scavenger receptors: role in innate immunity and microbial pathogenesis
Thomas Areschoug et al.
CELLULAR MICROBIOLOGY (2009)
Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial
Adi I. Daud et al.
CLINICAL CANCER RESEARCH (2009)
Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
Pamela Munster et al.
CLINICAL CANCER RESEARCH (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies
Ronald S. Flannagan et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
Thierry Roger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
Julie Delaloye et al.
PLOS PATHOGENS (2009)
Host innate immune receptors and beyond: Making sense of microbial infections
Ken J. Ishii et al.
CELL HOST & MICROBE (2008)
Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling
Wangsen Cao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code
Miriam Calao et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment
Konrad A. Bode et al.
IMMUNOLOGY (2007)
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M. Candelaria et al.
ANNALS OF ONCOLOGY (2007)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
Valproic acid (VPA) in patients with refractory advanced cancer:: a dose escalating phase I clinical trial
A. Atmaca et al.
BRITISH JOURNAL OF CANCER (2007)
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors:: A clinical and translational study
Pamela Muenster et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Jennifer L. Brogdon et al.
BLOOD (2007)
Signalling and phagocytosis in the orchestration of host defence
J. Magarian Blander
CELLULAR MICROBIOLOGY (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing
Chris D. Ellson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression
Hnin Thanda Aung et al.
FASEB JOURNAL (2006)
ETS transcription factors and regulation of immunity
Sarah Gallant et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
NF-κB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox
J Anrather et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1
T Roger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
WK Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
QC Ryan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression
T Roger et al.
BIOCHEMICAL JOURNAL (2005)
Nox enzymes and the biology of reactive oxygen
JD Lambeth
NATURE REVIEWS IMMUNOLOGY (2004)
Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies
FC Fang
NATURE REVIEWS MICROBIOLOGY (2004)
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid
CM Reilly et al.
JOURNAL OF IMMUNOLOGY (2004)
Macrophage migration inhibitory factor: A regulator of innate immunity
T Calandra et al.
NATURE REVIEWS IMMUNOLOGY (2003)
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
F Leoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Scavenger receptors in innate immunity
L Peiser et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta(2) integrins and selectin ligands
M Bunting et al.
CURRENT OPINION IN HEMATOLOGY (2002)
MIF regulates innate immune responses through modulation of Toll-like receptor 4
T Roger et al.
NATURE (2001)
Loss of PU.1 expression following inhibition of histone deacetylases
RN Laribee et al.
JOURNAL OF IMMUNOLOGY (2001)
Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis
CA Thomas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
